DEUTETRABENAZINE

N/A

Manufactured by Teva Neuroscience, Inc.

11,218 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DEUTETRABENAZINE

DEUTETRABENAZINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Teva Neuroscience, Inc.. The most commonly reported adverse reactions for DEUTETRABENAZINE include DRUG INEFFECTIVE, DEPRESSION, DYSKINESIA, DEATH, TREMOR. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DEUTETRABENAZINE.

Top Adverse Reactions

DRUG INEFFECTIVE924 reports
DEPRESSION463 reports
DYSKINESIA403 reports
DEATH402 reports
TREMOR330 reports
PRODUCT USE ISSUE321 reports
SOMNOLENCE305 reports
FATIGUE290 reports
SUICIDAL IDEATION287 reports
INSOMNIA281 reports
OFF LABEL USE267 reports
FALL262 reports
PRODUCT USE IN UNAPPROVED INDICATION239 reports
TARDIVE DYSKINESIA221 reports
DIZZINESS210 reports
ANXIETY189 reports
FEELING ABNORMAL167 reports
CONFUSIONAL STATE139 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES139 reports
PRODUCT DOSE OMISSION ISSUE139 reports
DIARRHOEA137 reports
NAUSEA134 reports
GAIT DISTURBANCE133 reports
HOSPITALISATION120 reports
RESTLESSNESS113 reports
BALANCE DISORDER112 reports
HEADACHE111 reports
ASTHENIA108 reports
DYSPNOEA108 reports
SPEECH DISORDER108 reports
PARKINSONISM105 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION102 reports
DRY MOUTH99 reports
CONDITION AGGRAVATED97 reports
DYSPHAGIA96 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE96 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS96 reports
MEMORY IMPAIRMENT89 reports
PAIN88 reports
AGITATION87 reports
DIABETES MELLITUS82 reports
INCORRECT DOSE ADMINISTERED79 reports
MALAISE78 reports
VOMITING77 reports
ADVERSE EVENT75 reports
HALLUCINATION73 reports
WEIGHT INCREASED73 reports
AGGRESSION71 reports
ADVERSE DRUG REACTION70 reports
DROOLING67 reports
THERAPY CESSATION66 reports
MOVEMENT DISORDER64 reports
AKATHISIA63 reports
WEIGHT DECREASED63 reports
DISTURBANCE IN ATTENTION60 reports
CONSTIPATION59 reports
DECREASED APPETITE59 reports
DEPRESSED MOOD57 reports
DRUG INTERACTION57 reports
CRYING56 reports
PRURITUS54 reports
URINARY TRACT INFECTION54 reports
PARKINSON^S DISEASE53 reports
DRUG TITRATION ERROR51 reports
HYPERSOMNIA50 reports
COUGH49 reports
INSURANCE ISSUE48 reports
MUSCLE TWITCHING48 reports
HUNTINGTON^S DISEASE47 reports
PALPITATIONS47 reports
SEDATION47 reports
DYSARTHRIA46 reports
GAIT INABILITY46 reports
RASH46 reports
DRUG HYPERSENSITIVITY45 reports
ILLNESS45 reports
MUSCULOSKELETAL STIFFNESS45 reports
LOSS OF CONSCIOUSNESS44 reports
PNEUMONIA44 reports
BACK PAIN43 reports
SLEEP DISORDER43 reports
BRUXISM42 reports
MOOD ALTERED42 reports
THERAPY INTERRUPTED42 reports
TIC42 reports
LETHARGY41 reports
MUSCULAR WEAKNESS41 reports
PAIN IN EXTREMITY41 reports
CEREBROVASCULAR ACCIDENT40 reports
CHEST PAIN40 reports
HYPERHIDROSIS40 reports
MUSCLE SPASMS40 reports
THERAPEUTIC PRODUCT EFFECT DECREASED40 reports
DRUG INTOLERANCE39 reports
THERAPY CHANGE39 reports
ANGER38 reports
BIPOLAR DISORDER38 reports
SEIZURE38 reports
ABDOMINAL DISCOMFORT37 reports
HYPERTENSION37 reports

Report Outcomes

Out of 6,444 classified reports for DEUTETRABENAZINE:

Serious 44.4%Non-Serious 55.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female3,878 (67.6%)
Male1,851 (32.3%)
Unknown5 (0.1%)

Reports by Age

Age 65159 reports
Age 71132 reports
Age 66131 reports
Age 64127 reports
Age 60126 reports
Age 67120 reports
Age 68120 reports
Age 72120 reports
Age 70118 reports
Age 63114 reports
Age 69113 reports
Age 62111 reports
Age 74100 reports
Age 7696 reports
Age 6194 reports
Age 5693 reports
Age 5893 reports
Age 7388 reports
Age 7583 reports
Age 5982 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DEUTETRABENAZINE?

This profile reflects 11,218 FDA FAERS reports that mention DEUTETRABENAZINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DEUTETRABENAZINE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, DEPRESSION, DYSKINESIA, DEATH, TREMOR, PRODUCT USE ISSUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DEUTETRABENAZINE?

Labeling and FAERS entries often list Teva Neuroscience, Inc. in connection with DEUTETRABENAZINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.